NCT03097380View on ClinicalTrials.gov

PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and Tiotropium

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

AZD2115

AZD2115

DRUG

SPIRIVA

Tiotropium

RADIATION

[11C]AZ13754366

Radioligand

Trial Locations (1)

171 76

Research Site, Stockholm

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY